<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0015131"><a href="http://purl.obolibrary.org/obo/MONDO_0015131">MONDO:0015131</a></h3>
<p><strong>Label:</strong> combined T cell and b cell immunodeficiency</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0012163">MONDO:0012163</a> (severe combined immunodeficiency, autosomal recessive, T cell-negative, b cell-positive, Nk cell-positive), <a href="http://purl.obolibrary.org/obo/MONDO_0017855">MONDO:0017855</a> (T-b- severe combined immunodeficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0015974">MONDO:0015974</a> (severe combined immunodeficiency (disease)), <a href="http://purl.obolibrary.org/obo/MONDO_0017854">MONDO:0017854</a> (T-b+ severe combined immunodeficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0018345">MONDO:0018345</a> (T+ b+ severe combined immunodeficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0009973">MONDO:0009973</a> (reticular dysgenesis), <a href="http://purl.obolibrary.org/obo/MONDO_0011476">MONDO:0011476</a> (MHC class i deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0016536">MONDO:0016536</a> (autosomal recessive lymphoproliferative disease), <a href="http://purl.obolibrary.org/obo/MONDO_0015975">MONDO:0015975</a> (hyper-IgM syndrome with susceptibility to opportunistic infections), <a href="http://purl.obolibrary.org/obo/MONDO_0015703">MONDO:0015703</a> (T-b+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta), <a href="http://purl.obolibrary.org/obo/MONDO_0018814">MONDO:0018814</a> (non-severe combined immunodeficiency),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_480549">Orphanet:480549</a>, <a href="http://www.orpha.net/ORDO/Orphanet_238505">Orphanet:238505</a>, <a href="http://www.orpha.net/ORDO/Orphanet_397802">Orphanet:397802</a>, <a href="http://purl.obolibrary.org/obo/OMIM_606843">OMIM:606843</a>, <a href="http://www.orpha.net/ORDO/Orphanet_169160">Orphanet:169160</a>, <a href="http://purl.obolibrary.org/obo/OMIM_241600">OMIM:241600</a>, <a href="http://purl.obolibrary.org/obo/OMIM_267500">OMIM:267500</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615122">OMIM:615122</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613011">OMIM:613011</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610163">OMIM:610163</a>, <a href="http://www.orpha.net/ORDO/Orphanet_317419">Orphanet:317419</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615617">OMIM:615617</a>, <a href="http://purl.obolibrary.org/obo/OMIM_604571">OMIM:604571</a>, <a href="http://www.orpha.net/ORDO/Orphanet_33355">Orphanet:33355</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615615">OMIM:615615</a>, <a href="http://www.orpha.net/ORDO/Orphanet_317416">Orphanet:317416</a>, <a href="http://purl.obolibrary.org/obo/OMIM_608971">OMIM:608971</a>, <a href="http://purl.obolibrary.org/obo/OMIM_308230">OMIM:308230</a>, <a href="http://www.orpha.net/ORDO/Orphanet_34592">Orphanet:34592</a>, <a href="http://www.orpha.net/ORDO/Orphanet_169154">Orphanet:169154</a>, <a href="http://www.orpha.net/ORDO/Orphanet_183663">Orphanet:183663</a>, <a href="http://www.orpha.net/ORDO/Orphanet_183660">Orphanet:183660</a>, <a href="http://www.orpha.net/ORDO/Orphanet_169157">Orphanet:169157</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000388">HP:0000388</a> (Otitis media) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system))) 41.14%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002719">HP:0002719</a> (Recurrent infections) and <a href="http://purl.obolibrary.org/obo/HP_0002721">HP:0002721</a> (Immunodeficiency) and <a href="http://purl.obolibrary.org/obo/HP_0011893">HP:0011893</a> (Abnormal leukocyte count) 41.14%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002721">HP:0002721</a> (Immunodeficiency) and <a href="http://purl.obolibrary.org/obo/HP_0004332">HP:0004332</a> (Abnormality of lymphocytes) and <a href="http://purl.obolibrary.org/obo/HP_0011893">HP:0011893</a> (Abnormal leukocyte count) 39.77%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002721">HP:0002721</a> (Immunodeficiency) and <a href="http://purl.obolibrary.org/obo/HP_0011893">HP:0011893</a> (Abnormal leukocyte count) 37.06%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000388">HP:0000388</a> (Otitis media) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology))) 36.61%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000388">HP:0000388</a> (Otitis media) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000315">HP:0000315</a> (Abnormality of the orbital region))) 36.61%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004332">HP:0004332</a> (Abnormality of lymphocytes) 36.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002715">HP:0002715</a> (Abnormality of the immune system) 32.42%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) 32.35%</li>
<li>Thing 31.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 31.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 28.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 28.24%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0005561">HP:0005561</a> (Abnormality of bone marrow cell morphology) 24.83%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) 24.05%</li>
</ul>
</body>
</html>
